India has cleared the first list of 13 countries for hydroxychloroquine (HCQ) which includes USA, Spain, Germany, Bahrain, Brazil, Nepal, Bhutan, Sri Lanka, Afghanistan, Maldives and Bangladesh, the sources said.
They said USA had asked for 48 lakh tablets of HCQ and India has sanctioned 35.82 lakh tablets, sources said.
Hydroxychloroquine is an anti-malarial drug deemed to be useful in dealing with COVID-19.
The sources said that India has also sent nine MT of Active Pharmaceutical Ingredient (API) to the US in line with its request.
They said Brazil and Canada are expected to get 50 lakh tablets of hydroxychloroquine in the second consignment. In the first consignment, Brazil will receive 0.53 MT of API.
The sources said Bangladesh will get 20 lakh tablets of hydroxychloroquine, Nepal 10 lakh, Bhutan 2 lakh, Sri Lanka 10 lakh (not in the first consignment), Afghanistan 5 lakh, and Maldives 2 lakh.
They said Germany will also get 50 lakh tablets of HCQ in the second consignment and in the first consignment, it will receiving 1.5 MT API.
The other countries to receive hydroxychloroquine include Seychelles and Dominican Republic.
The sources said India will be sending a total of 14 million tablets and 13.5 MT API.
US President Donald Trump on Wednesday thanked Prime Minister Narendra Modi for allowing the export of HCQ. In a tweet he had also thanked India and the Indian people for the decision on HCQ, saying it will not be forgotten.
Israeli Prime Minister Benjamin Netanyahu also thanked India for sending chloroquine.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
